
Posts by admin
SLU-PP-332 Explained: What the ERR Agonist Exercise Mimetic Does
A Short Primer
SLU-PP-332 is a small-molecule pan-agonist of the three estrogen-related receptor (ERR) isoforms — ERRα, ERRβ, and ERRγ...
Testagen Peptide Side Effects and Clinical Monitoring
The Short Answer
In the published peptide bioregulator literature, Testagen has a favorable general safety profile with minimal report...
Testagen Dosage and Protocol Guide for Clinicians
Context for Prescribers
Because Testagen is not an FDA-approved therapy and commercial prescribing information does not exist, clinici...
Testagen for Women: Peptide Bioregulators and Female Hormone Balance
A Question That Keeps Coming Up
Physicians working with peptide bioregulators increasingly see questions from female patients about Te...
Testagen vs Testosterone (TRT): Why Peptide Bioregulators Work Differently
The Short Answer
Testagen and testosterone replacement therapy (TRT) are not substitutes for one another. They represent two fundament...
What Is Testagen? A Physician’s Guide to the Testes Peptide Bioregulator
What Is Testagen?
Testagen is a short-chain peptide bioregulator originally developed within the Russian school of gerontopeptide rese...
FDA Removes 12 Peptides from 503A Category 2
The FDA’s April 2026 update regarding compounded peptides has sent ripples through the regenerative medicine community. For clinical pr...
Top 10 Nutraceutical Private Label Companies in 2026: Expert Rankings for Healthcare Practices
Physicians and clinic operators are realizing that recommending third-party supplements often means sending patients away to spend mone...
Top 10 Compounding Pharmacies in 2026: Expert Rankings & Reviews
Finding a reliable compounding pharmacy requires more than a simple internet search. Healthcare providers and patients alike need a par...
Working with Compounding Pharmacies: Provider & Patient Guide
Navigating the logistics of a compounding pharmacy requires a clear understanding of specialized workflows. Retail pharmacies operate o...











